Effect of a synthetic thrombin-inhibitor MD805 on the reaction between thrombin and plasma antithrombin-III

Travis, 1983, Human plasma proteinase inhibitors, Ann. Rev. Biochem., 52, 655, 10.1146/annurev.bi.52.070183.003255 Egeberg, 1965, Inherited antithrombin III deficiency causing thrombophilia, Thrombos. Diathes. haemorrh. (Stuttg.), 13, 516 Odegard, 1975, Heparin cofactor activity measured with an amidolytic method, Thromb. Res., 6, 287, 10.1016/0049-3848(75)90078-X Okamoto, 1975, A novel series of synthetic thrombin-inhibitor having extremely potent and highly selective action, Kobe J. Med. Sci., 21, 43 Okamoto, 1981, Potent inhibition of thrombin by the newly synthesized arginine derivative No.805, 101, 440 Okamoto, 1976, A new series of synthetic thrombin-inhibitors (OM-inhibitors) having extremely potent and selective action, Thromb. Res., 8, 77, 10.1016/0049-3848(76)90049-9 Tamao, 1986, Effect of a selective thrombin inhibitor MCI-9038 on fibrinolysis in vitro and in vivo, Thrombos. Haemost. (Sttutg.), 56, 28, 10.1055/s-0038-1661597 Hijikata-Okunomiya, 1987, Effect of MD-805 on plasminogen activator release by thrombin from isolated perfused dog leg, Thromb. Res., 45, 699, 10.1016/0049-3848(87)90334-3 Kikumoto, 1984, Selective inhibition of thrombin by (2R,4R)-4-methyl-1-[N2-[(3-methyl-1,2,3,4-tetrahydro-8-quinolinyl)sulfonyl]-l-arginyl]-2-piperidinecarboxylic acid, Biochemistry, 23, 85, 10.1021/bi00296a014 Hijikata-Okunomiya, 1987, Similarity and dissimilarity in the stereogeometry of the active sites of thrombin, trypsin, plasmin, and glandular kallikrein, Thromb. Res., 45, 451, 10.1016/0049-3848(87)90308-2 Bjork, 1981, The site in human antithrombin for functional proteolytic cleavage by human thrombin, FEBS Lett., 126, 257, 10.1016/0014-5793(81)80255-4 Kitz, 1962, Esters of methanesulfonic acid as irreversible inhibitors of acetylcholinesterase, J. Biol. Chem., 237, 3245, 10.1016/S0021-9258(18)50153-8 Pelzer, 1988, Determination of human thrombin-antithrombin III complex in plasma with an enzyme-linked immunosorbent assay, Thrombos. Haemost. (Stuttg.), 59, 101, 10.1055/s-0038-1646768 Rosenberg, 1973, The purification and mechanism of action of human antithrombin-heparin cofactor, J. Biol. Chem., 248, 6490, 10.1016/S0021-9258(19)43472-8 Hemker, 1971, The evaluation of the two-stage prothrombin assay, Thrombos. Diathes. haemorrh. (Stuttg.), 25, 545 Hijikata-Okunomiya, A. Unpublished data. Markwardt, 1973, The influence of synthetic thrombin inhibitors on the thrombin-antithrombin reaction, Thromb. Res., 2, 343, 10.1016/0049-3848(73)90044-3 Markwardt, 1968, Comparative studies on the inhibition of trypsin, plasmin and thrombin by derivatives of benzamidine, Eur. J. Biochem., 6, 502, 10.1111/j.1432-1033.1968.tb00473.x Sturzebecher, 1976, Synthetic inhibitors of serine proteinases. XIV. Inhibition of factor Xa by derivatives of benzamidine, Thromb. Res., 9, 637, 10.1016/0049-3848(76)90110-9 Hijikata, 1979, Kinetic studies on the selectivity of a synthetic thrombin-inhibitor using synthetic peptide substrates, Thrombos. Haemostas., 42, 1039, 10.1055/s-0038-1656995